Clinical Trials Browser

OTHER × Borderline Resectable Pancreatic Adenocarcinoma × Radiotherapy × Clear all

NCT04481204 2026-04-15

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Phase 2 Active not recruiting

Gastrointestinal

Borderline Resectable Pancreatic Adenocarcinoma

NCT02394535 2022-09-02

Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Borderline Resectable Pancreatic Adenocarcinoma